Immunoreactivity against SLC3A2 in high grade gliomas displays positive correlation with glioblastoma patient survival: Potential target for glioma diagnosis and therapy https://www.biorxiv.org/content/10.1101/2023.01.26.525653v1?med=mas
Immunoreactivity against SLC3A2 in high grade gliomas displays positive correlation with glioblastoma patient survival: Potential target for glioma diagnosis and therapy https://www.biorxiv.org/content/10.1101/2023.01.26.525653v1?med=mas